Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

• Published in: Frontiers in immunology Vol. 13; p. 843928
• Main Authors: Zhang, Zhan, Shen, Qi, Chang, Haocai
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 27.04.2022
• Subjects: antigen selection; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines; Humans; Immunology; Pandemics - prevention & control; prevention; SARS-CoV-2; Vaccines; COVID-19; COVID-19 vaccines; SARS-CoV-2; antigen selection; prevention
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.843928

The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public health all over the world. Currently, optimal COVID-19 management involves effective vaccination. Vaccination is known to greatly enhance immune response against viral infections and reduce public transmission of COVID-19. However, although current vaccines offer some benefits, viral variations and other factors demand the continuous development of vaccines to eliminate this virus from host. Hence, vaccine research and development is crucial and urgent to the elimination of this pandemic. Herein, we summarized the structural and replicatory features of SARS-CoV-2, and focused on vaccine-mediated disease prevention strategies like vaccine antigen selection, vaccine research, and vaccine application. We also evaluated the latest literature on COVID-19 and extensively reviewed action mechanisms, clinical trial (CT) progresses, advantages, as well as disadvantages of various vaccine candidates against SARS-CoV-2. Lastly, we discussed the current viral treatment, prevention trends, and future prospects.